Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biomarkers in multiple sclerosis.
Patient perceptions of multiple sclerosis and its treatment.
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
Solitary sclerosis: Progressive neurological deficit from a spatially isolated demyelinating lesion: A further report.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Genetics of primary progressive multiple sclerosis.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Guillain-Barré syndrome in Colombia: where do we stand now?
Low dose naltrexone therapy in multiple sclerosis.
[Posture disorders in patients with multiple sclerosis.]
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial.
Rectus abdominis muscle endometriotic mass in a woman affected by multiple sclerosis.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
A gender-related action of IFNbeta-therapy was found in multiple sclerosis.
Pages
« first
‹ previous
…
131
132
133
134
135
136
137
138
139
…
next ›
last »